Printer Friendly
The Free Library
14,504,712 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Register Now For BioPartnering Europe to Access Europe's Most Productive Networking Life Science Conference.


LONDON -- Technology Vision Group LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 is pleased to announce that the 14th Annual BioPartnering Europe conference (BPE BPE
abbr.
Bachelor of Physical Education
) will once again be held in London, England on October 8 -- 10, 2006. BPE is Europe's longest running life science partnering conference consistently attracting decision makers from a broad cross section of the life science industry and providing the perfect environment to conduct biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 business. Last year nearly 1200 international delegates attended BPE, where they participated in well over 4,000 confirmed meetings using biopartnering.com software over the course of two days, with numerous other ad hoc For this purpose. Meaning "to this" in Latin, it refers to dealing with special situations as they occur rather than functions that are repeated on a regular basis. See ad hoc query and ad hoc mode.  meetings. For full details of how to register for BPE, and take advantage of the Early Bird delegate A person who is appointed, authorized, delegated, or commissioned to act in the place of another. Transfer of authority from one to another. A person to whom affairs are committed by another.

A person elected or appointed to be a member of a representative assembly.
 rate (available until August 31) please see: http://www.techvision.com/bpe/registration/. E[acute accent acute accent
n.
A mark (´) indicating:
a. that a vowel is close or tense, as é in French été.

b. that a vowel or syllable has a high or rising pitch, as in Chinese or Ancient Greek.

c.
]Dr. Niels Emmerich, Chief Operations Officer of German-based immatics biotechnologies GmbH commented, "I was impressed im·press 1  
tr.v. im·pressed, im·press·ing, im·press·es
1. To affect strongly, often favorably:
 by the number and quality of meetings I had in less than 2 days. BPE is highly recommended!"

E[acute accent]Present your company to world leading decision makers

E[acute accent]BPE offers innovative ways for pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
 to showcase their businesses to top decision makers from leading pharmaceutical, biotechnology, service, and financial organizations. Choose from either 2.5 hour Open House presentations or 14-minute podium podium

In architecture, a pedestal on a large scale. It may be any of various elements that form the base of a structure, such as the platform forming the floor and substructure of a Classical temple, a low wall supporting columns, or the structurally or decoratively
 speaker presentations for emerging biotech companies. Slots for both are filling up fast, so be sure to apply immediately at http://www.techvision.com/bpe/registration/presenter/apply.php. E[acute accent]"2006 will be my tenth BioPartnering Europe. Since 1997, I have represented a number of emerging biotechnology companies and have consistently found BPE to be the premier European European

emanating from or pertaining to Europe.


European bat lyssavirus
see lyssavirus.

European beech tree
fagussylvaticus.

European blastomycosis
see cryptococcosis.
 event for partnering and deal-making," commented Dr. Simon Kerry, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Karus Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
 Ltd.

E[acute accent]biopartnering.com fosters B2B (Business to Business) Refers to one business communicating with or selling to another. See B2B e-commerce, B2C and B2G.

B2B - business to business
 opportunities

E[acute accent]biopartnering.com, BPE's online partnering system is now live. The collaboration tool A collaboration tool is something that helps people collaborate. The term is often used to mean collaborative software, but collaboration tools were being used before computers existed, a piece of paper can for example can be used as collaboration tool.  enables delegates to search for partnering opportunities through keyword searches of detailed profiles on all companies, contact other delegates, arrange private meetings and reserve meeting rooms in advance of the conference. E[acute accent]Full details about BioPartnering Europe online at: http://www.techvision.com.
Conference Sponsors and Supporters

Producer:
Technology Vision Group LLC

Premium Sponsors
AstraZeneca, Taylor Wessing

Gold Sponsors
Cooley Godward LLP, Deloitte, Ferghana Partners Group

Silver Sponsors
Amgen, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson &
Johnson, Merck & Co., Inc., Novartis, Pfizer, Roche, TAP
Pharmaceutical Products Inc., Welsh Development Agency -- Bioscience
Unit

Conference Sponsors
Farris, Vaughan, Wills, & Murphy LLP, Genzyme, Life Science Analytics,
NovaQuest

Conference Supporters
BayBio, BioCentury, Business Wire, Citigate, Global Bioscience
Partnership, Nature Biotechnology, Red Herring, U.S. Commercial
Service

Official Carrier
British Airways

Emerging Company Presenters
Alchemia Limited, Antibe Therapeutics Inc., Avexa Limited, BioXell
SpA, Borean Pharma A/S, BT Pharma, Celldex Therapeutics, CGK, Co.
Ltd., Clera, Inc., EcoBiotics Ltd., GammaCan Int. Inc., Haptogen Ltd.,
hemoCORM, Karus Therapeutics, Lymphosign Inc., Mimetogen
Pharmaceuticals, MNLpharma Ltd., ODC Therapy, PolyMedix Inc.,
ProtAffin Biotechnologie AG, Psynova Ltd., SantoSolve, Senexis Ltd.,
Syntaxin, Y's Therapeutics

Open House Presenters
Ablynx, ACE BioSciences A/S, Acrux Ltd., Aegera Therapeutics Inc.,
AerovectRx Corporation, AlgoNomics NV, Alligator Bioscience, amaxa
GmbH, Ambit Biosciences, Amorfix Life Sciences Ltd., AmpliMed
Corporation, Antisoma, Arrow Therapeutics Ltd., Astex Therapeutics
Ltd., Avecia Biotechnology, Avera Pharmaceuticals, Inc., Avid
Bioservices, Avidex, BioFocus, Biolex Therapeutics, Boston Life
Sciences, Inc., Callisto Pharmaceuticals, CombinatoRx, Covx, Curis,
Inc., Cylene Pharmaceuticals Inc., Cytokinetics, Inc., Dako North
America, Digilab BioVisioN GmbH, Direvo Biotech AG, Emergent
Biosolutions, Evolutec, Evotec (UK) Ltd., ExonHit Therapeutics,
Favrille, Inc., Fermavir Pharmaceuticals Inc., Gala Biotech, a
business unit of Cardinal Health, GangaGen Inc., Health Protection
Agency, Icagen, Inc., ImmuPharma PLC, INC DataSpectrum, Indevus
Pharmaceuticals, Inc., Ingenium Pharmaceuticals AG, Inimex
Pharmaceuticals, Inc., InNexus Biotechnology Inc., Intendis GmbH,
Intermune, Inc., Intronn Inc., Istituto Superiore di Sanita, Jurilab
Ltd., Liponex Inc., Locus Pharmaceuticals, MaxCyte, Inc., Medicago
Inc., MedPharm Ltd, Miltenyi Bioprocess, MolMed SpA, Monash Commercial
Pty Ltd, MorphoSys AG, Nerites Corporation, Novozymes A/S, OctoPlus,
Orient EuroPharma Ltd. Co., Ltd., Oxxon Therapeutics Ltd., Paradigm
Therapeutics Ltd., Perceptronix Medical Inc., Phylogica Ltd., PIramed
Ltd., Portola Pharmaceuticals, PTC Therapeutics, Inc., Rincon
Pharmaceuticals, Inc., RNTECH/DNAVision, Sapphire Therapeutics,
Scottish Biomedical, SGX Pharmaceuticals, Inc., SR Pharma / Atugen AG,
Stem Cell Therapeutics, Threshold Pharmaceuticals, TiGenix NV,
TopoTarget UK Ltd., Trigen Holdings AG, Tripos Discovery Research
Ltd., UCB Celltech, Urigen, Warwick Effect Polymers Ltd., WuXi
PharmaTech Co. Ltd., Xenome Ltd, XOMA Ltd., ZIOPHARM Oncology, Inc
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 5, 2006
Words:720
Previous Article:JDA Announces Conference Call Details for Manugistics Acquisition Completion and Preliminary Second Quarter 2006 Earnings Results.
Next Article:FSN Bay Area and Bay Area Rapid Transit Announce 2006 Athletics & Giants Collectors' Series Promotion; FSN Bay Area Collectors' Series Features...



Related Articles
Technology Vision Group LLC Launches biopartnering.com to Facilitate Pharma-Biotech Deal Making at BioPartnering North America 2004.
Powerful Internet Tool is Key Feature of Biopartnering North America; biopartnering.com Allows Delegates to Fully Utilize their Attendance at BPN.
Exciting New Addition to European C21 Programme; Business Plan Competition Applications Are Being Accepted for the 5th Annual European C21...
EC21 BioVentures Conference Continues to Grow.
BioPartnering Europe Opens the World Life Science Week, 9-13 October 2005, in London; Register Now for BPE to Access Europe's Most Productive...
BioPartnering Europe -- BPE -- Programme Highlights the Hottest Topics in the Biotech Industry Today.
BioPartnering North America Calls for Applications to Present 5-7 February 2006, Vancouver, B.C., Canada; Unique Opportunity for Biotech Companies to...
BioPartnering Europe Offers a Host of Partnering and Networking Opportunities.
Gazprom Gains Foothold In Southern European Market Through Deal With ENI.
Meeting report: national workshops for the communication of air pollution and health information: summary of four workshops in different regions of...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles